insights_auto
Why is SBHMY up 10.82%?
Dive Deeperchevron_right
SBHMY:OTCMKTS
Sino Biopharmaceutical Unsponsored Caymand Islands ADR
$16.28
arrow_upward
+10.82%(+1.59) 1D
Oct 1, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SBHMY...
Open
$16.28
High
$16.28
Low
$16.28
Mkt. cap
104.44B
Avg. vol.
508.00
Volume
143.00
52-wk high
$20.01
52-wk low
$11.27
Beta
0.42
Shares outstanding
934.15M
No. of employees
23K
Open
$16.28
High
$16.28
Low
$16.28
Mkt. cap
104.44B
Avg. vol.
508.00
Volume
143.00
52-wk high
$20.01
52-wk low
$11.27
Beta
0.42
Shares outstanding
934.15M
No. of employees
23K
News stories
From web sources and news partners
The Motley Fool
·
11 minutes ago
Prediction: 2 Space Stocks That Could Join SpaceX and Rocket Lab in the Nasdaq-100 by 2030
MarketBeat
·
2 minutes ago
Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Stock Has Consensus Price Target of $147.13 According to Analysts
Yahoo Finance
·
37 minutes ago
Stock Market: Will S&P 500 Open Up or Down Today?
Profile
Sino Biopharmaceutical Limited, shortly SBP Group, is a pharmaceutical conglomerate in China. The Company was listed on the Hong Kong Stock Exchange in 2000 and included in 2013 as a constituent stock of MSCI Global Standard Indices – MSCI China Index, Hang Seng Index in 2018, Hang Seng China Enterprises Index in 2019, and Hang Seng Connect Biotech 50 Index and Hang Seng China 25 Index in 2020.
The Group’s principal subsidiaries include: Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Beijing Tide Pharmaceutical Co. Ltd., Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. and invoX Pharma Limited. Its products including biopharmaceutical and chemical medicines are used in a host of therapeutic areas, such as tumors, liver diseases, respiratory system diseases and surgery/analgesia. Wikipedia
About Sino Biopharmaceutical Unsponsored Caymand Islands ADR